SB0384

2013 Regular Session

 

Entitled:

Economic Development - Sickle Cell Disease Research Program

Sponsored by:

Senator Pugh

Status:

In the House - Hearing 3/26 at 1:00 p.m.


Synopsis:Establishing the Sickle Cell Disease Research Program to be administered by the Maryland Technology Development Corporation to provide grants for sickle cell disease research projects; establishing the purposes of the Program; establishing specified types of grants to be awarded under the Program; establishing the Sickle Cell Disease Research Fund in the Corporation; providing for the purpose and composition of the Fund; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Senators Pugh, Astle, Benson, Conway, Currie, DeGrange, Dyson, Forehand, Garagiola, Getty, Glassman, Jacobs, Jones-Rodwell, Kelley, King, Kittleman, Klausmeier, Madaleno, Mathias, McFadden, Montgomery, Muse, Peters, Raskin, Robey, and Stone
Additional Facts:Cross-filed with: HB0726
Introduced in a prior session as: HB1026 Session: 2012 Regular Session
Bill File Type: Regular
Effective Date(s): October 1, 2013
Committee(s):
Finance  Listen to Committee HearingHealth and Government Operations  View Committee Hearing
Broad Subject(s):Economic and Community Development
Narrow Subject(s):Appropriations
Commerce and Business -see also- Dealers; Elec. Comm.; etc.
Diseases -see also- AIDS; Rabies
Grants
Industry and Technology
Loans -see also- Mortgages
Medical Research
Public Corporations and Instrumentalities
Reports
Revenue and Taxes -see also- Dev Fees &Taxes; specific tax
Rules and Regulations
Statutes:Article - Economic Development
(10-463 through 10-468)
Article - State Finance and Procurement
(6-226)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


October 2, 2015 9:12 A.M.